Table of Contents

2019-2024 Global Durvalumab Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Durvalumab Consumption 2014-2024
2.1.2 Durvalumab Consumption CAGR by Region
2.2 Durvalumab Segment by Type
2.2.1 2.4mL Injection
2.2.2 10mL Injection
2.3 Durvalumab Consumption by Type
2.3.1 Global Durvalumab Consumption Market Share by Type (2014-2019)
2.3.2 Global Durvalumab Revenue and Market Share by Type (2014-2019)
2.3.3 Global Durvalumab Sale Price by Type (2014-2019)
2.4 Durvalumab Segment by Application
2.4.1 Locally Advanced Urothelial Carcinoma
2.4.2 Metastatic Urothelial Carcinoma
2.4.3 Other
2.5 Durvalumab Consumption by Application
2.5.1 Global Durvalumab Consumption Market Share by Application (2014-2019)
2.5.2 Global Durvalumab Value and Market Share by Application (2014-2019)
2.5.3 Global Durvalumab Sale Price by Application (2014-2019)

3 Global Durvalumab by Manufacturers
3.1 Global Durvalumab Sales Market Share by Manufacturers
3.1.1 Global Durvalumab Sales by Manufacturers (2017-2019)
3.1.2 Global Durvalumab Sales Market Share by Manufacturers (2017-2019)
3.2 Global Durvalumab Revenue Market Share by Manufacturers
3.2.1 Global Durvalumab Revenue by Manufacturers (2017-2019)
3.2.2 Global Durvalumab Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Durvalumab Sale Price by Manufacturers
3.4 Global Durvalumab Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Durvalumab Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Durvalumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Durvalumab by Regions
4.1 Durvalumab by Regions
4.1.1 Global Durvalumab Consumption by Regions
4.1.2 Global Durvalumab Value by Regions
4.2 Americas Durvalumab Consumption Growth
4.3 APAC Durvalumab Consumption Growth
4.4 Europe Durvalumab Consumption Growth
4.5 Middle East & Africa Durvalumab Consumption Growth

5 Americas
5.1 Americas Durvalumab Consumption by Countries
5.1.1 Americas Durvalumab Consumption by Countries (2014-2019)
5.1.2 Americas Durvalumab Value by Countries (2014-2019)
5.2 Americas Durvalumab Consumption by Type
5.3 Americas Durvalumab Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Durvalumab Consumption by Countries
6.1.1 APAC Durvalumab Consumption by Countries (2014-2019)
6.1.2 APAC Durvalumab Value by Countries (2014-2019)
6.2 APAC Durvalumab Consumption by Type
6.3 APAC Durvalumab Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Durvalumab by Countries
7.1.1 Europe Durvalumab Consumption by Countries (2014-2019)
7.1.2 Europe Durvalumab Value by Countries (2014-2019)
7.2 Europe Durvalumab Consumption by Type
7.3 Europe Durvalumab Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Durvalumab by Countries
8.1.1 Middle East & Africa Durvalumab Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Durvalumab Value by Countries (2014-2019)
8.2 Middle East & Africa Durvalumab Consumption by Type
8.3 Middle East & Africa Durvalumab Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Durvalumab Distributors
10.3 Durvalumab Customer

11 Global Durvalumab Market Forecast
11.1 Global Durvalumab Consumption Forecast (2019-2024)
11.2 Global Durvalumab Forecast by Regions
11.2.1 Global Durvalumab Forecast by Regions (2019-2024)
11.2.2 Global Durvalumab Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Durvalumab Forecast by Type
11.8 Global Durvalumab Forecast by Application

12 Key Players Analysis
12.1 Medimmune (AstraZeneca)
12.1.1 Company Details
12.1.2 Durvalumab Product Offered
12.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Medimmune (AstraZeneca) News
..

13 Research Findings and Conclusion